SCYNEXIS, Inc. Operating Expenses
SCYNEXIS, Inc. (SCYX) reported Operating Expenses of $8.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-10
- SCYNEXIS, Inc. operating expenses for the quarter ending 2026-06-30 was $8.01M, a 26.68% decline year-over-year.
- SCYNEXIS, Inc. operating expenses for the quarter ending 2026-03-31 was $16.94M, a 91.03% increase year-over-year.
- SCYNEXIS, Inc. operating expenses for the quarter ending 2025-12-31 was $8.13M, a 10.02% decline year-over-year.
- SCYNEXIS, Inc. operating expenses for the quarter ending 2025-09-30 was $8.74M, a 20.41% decline year-over-year.
- SCYNEXIS, Inc. operating expenses for fiscal 2025 was $36.67M, a 10.25% decline from fiscal 2024.
- SCYNEXIS, Inc. operating expenses for fiscal 2024 was $40.86M, a 39.44% decline from fiscal 2023.
- SCYNEXIS, Inc. operating expenses for fiscal 2023 was $67.47M, a 25.73% decline from fiscal 2022.
- SCYNEXIS, Inc. operating expenses for fiscal 2022 was $90.85M, a 22.77% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.01M 10-Q · filed 2026-08-10 | $24.95M 10-Q · filed 2026-08-10 | $33.07M derived: sum of 3 quarters · filed 2026-08-10 | $41.81M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $16.94M 10-Q · filed 2026-05-11 | $25.06M derived: sum of 2 quarters · filed 2026-05-11 | $33.80M derived: sum of 3 quarters · filed 2026-05-11 | $44.73M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $8.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $16.86M derived: sum of 2 quarters · filed 2026-03-04 | $27.79M derived: sum of 3 quarters · filed 2026-08-10 | $36.67M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | $8.74M 10-Q · filed 2025-11-05 | $19.66M derived: sum of 2 quarters · filed 2026-08-10 | $28.55M 10-Q · filed 2025-11-05 | $37.56M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $10.93M 10-Q · filed 2026-08-10 | $19.81M 10-Q · filed 2026-08-10 | $28.82M derived: sum of 3 quarters · filed 2026-08-10 | $39.80M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $8.87M 10-Q · filed 2026-05-11 | $17.90M derived: sum of 2 quarters · filed 2026-05-11 | $28.88M derived: sum of 3 quarters · filed 2026-05-11 | $38.85M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $20.01M derived: sum of 2 quarters · filed 2026-03-04 | $29.98M derived: sum of 3 quarters · filed 2026-03-04 | $40.86M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | $10.98M 10-Q · filed 2025-11-05 | $20.95M derived: sum of 2 quarters · filed 2025-11-05 | $31.83M 10-Q · filed 2025-11-05 | $60.70M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $9.97M 10-Q · filed 2025-08-13 | $20.85M 10-Q · filed 2025-08-13 | $49.72M derived: sum of 3 quarters · filed 2025-08-13 | $61.58M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $10.88M 10-Q · filed 2025-05-15 | $39.74M derived: sum of 2 quarters · filed 2025-05-15 | $51.60M derived: sum of 3 quarters · filed 2025-05-15 | $66.54M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $28.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $40.72M derived: sum of 2 quarters · filed 2025-03-12 | $55.66M derived: sum of 3 quarters · filed 2025-03-12 | $67.47M 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | $11.86M 10-Q · filed 2024-11-06 | $26.80M derived: sum of 2 quarters · filed 2024-11-06 | $38.61M 10-Q · filed 2024-11-06 | $62.62M derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | $14.94M 10-Q · filed 2024-08-08 | $26.75M 10-Q · filed 2024-08-08 | $50.76M derived: sum of 3 quarters · filed 2024-08-08 | $74.11M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $11.81M 10-Q · filed 2024-05-08 | $35.82M derived: sum of 2 quarters · filed 2024-05-08 | $59.17M derived: sum of 3 quarters · filed 2024-05-08 | $82.24M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $47.36M derived: sum of 2 quarters · filed 2024-03-28 | $70.42M derived: sum of 3 quarters · filed 2024-03-28 | $90.85M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $23.36M 10-Q · filed 2023-11-13 | $46.42M derived: sum of 2 quarters · filed 2023-11-13 | $66.84M 10-Q · filed 2023-11-13 | $89.74M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $23.06M 10-Q · filed 2023-08-14 | $43.48M 10-Q · filed 2023-08-14 | $66.38M derived: sum of 3 quarters · filed 2023-08-14 | $86.34M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $20.43M 10-Q · filed 2023-05-10 | $43.32M derived: sum of 2 quarters · filed 2023-05-10 | $63.28M derived: sum of 3 quarters · filed 2023-05-10 | $80.78M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $22.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $42.85M derived: sum of 2 quarters · filed 2023-03-31 | $60.36M derived: sum of 3 quarters · filed 2023-03-31 | $74.00M 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $19.96M 10-Q · filed 2022-11-09 | $37.47M derived: sum of 2 quarters · filed 2022-11-09 | $51.11M 10-Q · filed 2022-11-09 | $66.45M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $17.51M 10-Q · filed 2022-08-15 | $31.15M 10-Q · filed 2022-08-15 | $46.49M derived: sum of 3 quarters · filed 2022-08-15 | $58.00M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $13.64M 10-Q · filed 2022-05-12 | $28.98M derived: sum of 2 quarters · filed 2022-05-12 | $40.49M derived: sum of 3 quarters · filed 2022-05-12 | $52.32M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $15.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $26.85M derived: sum of 2 quarters · filed 2022-03-29 | $38.67M derived: sum of 3 quarters · filed 2022-03-29 | $51.15M 10-K · filed 2022-03-29 | ||||
| 2020-09-30 | $11.51M 10-Q · filed 2021-11-10 | $23.34M derived: sum of 2 quarters · filed 2021-11-10 | $35.81M 10-Q · filed 2021-11-10 | $49.92M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $11.83M 10-Q · filed 2021-08-16 | $24.30M 10-Q · filed 2021-08-16 | $38.41M derived: sum of 3 quarters · filed 2021-08-16 | $50.17M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $12.48M 10-Q · filed 2021-05-17 | $26.59M derived: sum of 2 quarters · filed 2021-05-17 | $38.34M derived: sum of 3 quarters · filed 2021-05-17 | $49.59M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $14.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $25.86M derived: sum of 2 quarters · filed 2021-03-29 | $37.12M derived: sum of 3 quarters · filed 2021-03-29 | $49.04M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $11.76M 10-Q · filed 2020-11-06 | $23.01M derived: sum of 2 quarters · filed 2020-11-06 | $34.94M 10-Q · filed 2020-11-06 | $43.79M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $11.25M 10-Q · filed 2020-08-10 | $23.18M 10-Q · filed 2020-08-10 | $32.03M derived: sum of 3 quarters · filed 2020-08-10 | $38.40M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $11.93M 10-Q · filed 2020-05-11 | $20.78M derived: sum of 2 quarters · filed 2020-05-11 | $27.14M derived: sum of 3 quarters · filed 2020-05-11 | $34.87M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $8.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $15.22M derived: sum of 2 quarters · filed 2020-03-11 | $22.94M derived: sum of 3 quarters · filed 2020-03-11 | $30.24M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $6.37M 10-Q · filed 2019-11-12 | $14.09M derived: sum of 2 quarters · filed 2019-11-12 | $21.39M 10-Q · filed 2019-11-12 | $28.61M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $7.72M 10-Q · filed 2019-08-07 | $15.02M 10-Q · filed 2019-08-07 | $22.24M derived: sum of 3 quarters · filed 2019-08-07 | $28.71M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $7.30M 10-Q · filed 2019-05-08 | $14.52M derived: sum of 2 quarters · filed 2019-05-08 | $20.98M derived: sum of 3 quarters · filed 2019-05-08 | $27.79M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $13.69M derived: sum of 2 quarters · filed 2019-03-14 | $20.50M derived: sum of 3 quarters · filed 2019-03-14 | $26.58M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | $6.46M 10-Q · filed 2018-11-13 | $13.27M derived: sum of 2 quarters · filed 2018-11-13 | $19.35M 10-Q · filed 2018-11-13 | $25.05M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $6.81M 10-Q · filed 2018-08-09 | $12.89M 10-Q · filed 2018-08-09 | $18.58M derived: sum of 3 quarters · filed 2018-08-09 | $25.35M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $6.08M 10-Q · filed 2018-05-08 | $11.78M derived: sum of 2 quarters · filed 2018-05-08 | $18.55M derived: sum of 3 quarters · filed 2018-05-08 | $26.88M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $12.46M derived: sum of 2 quarters · filed 2018-03-13 | $20.80M derived: sum of 3 quarters · filed 2018-03-13 | $28.07M 10-K · filed 2018-03-13 | ||||
| 2016-09-30 | $6.77M 10-Q · filed 2017-11-07 | $15.10M derived: sum of 2 quarters · filed 2017-11-07 | $22.38M 10-Q · filed 2017-11-07 | $30.83M derived: sum of 4 quarters · filed 2017-11-07 | ||||
| 2016-06-30 | $8.33M 10-Q · filed 2017-08-08 | $15.61M 10-Q · filed 2017-08-08 | $24.06M derived: sum of 3 quarters · filed 2017-08-08 | $31.66M derived: sum of 4 quarters · filed 2017-08-08 | ||||
| 2016-03-31 | $7.28M 10-Q · filed 2017-05-08 | $15.73M derived: sum of 2 quarters · filed 2017-05-08 | $23.33M derived: sum of 3 quarters · filed 2017-05-08 | $29.89M derived: sum of 4 quarters · filed 2017-05-08 | ||||
| 2015-12-31 | $8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $16.05M derived: sum of 2 quarters · filed 2017-03-13 | $22.61M derived: sum of 3 quarters · filed 2017-03-13 | $28.61M 10-K · filed 2017-03-13 | ||||
| 2015-09-30 | $7.60M 10-Q · filed 2016-11-07 | $14.16M derived: sum of 2 quarters · filed 2016-11-07 | $20.15M 10-Q · filed 2016-11-07 | $24.86M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-06-30 | $6.56M 10-Q · filed 2016-08-08 | $12.55M 10-Q · filed 2016-08-08 | $17.25M derived: sum of 3 quarters · filed 2017-03-13 | $21.85M derived: sum of 4 quarters · filed 2017-03-13 | ||||
| 2015-03-31 | $6.00M 10-Q · filed 2016-05-09 | $6.45M 10-Q · filed 2015-05-15 | $10.70M derived: sum of 2 quarters · filed 2017-03-13 | $15.30M derived: sum of 3 quarters · filed 2017-03-13 | $19.37M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2014-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $9.30M derived: sum of 2 quarters · filed 2017-03-13 | $13.38M derived: sum of 3 quarters · filed 2017-03-13 | $15.90M 10-K · filed 2017-03-13 | $15.69M 10-K · filed 2015-03-30 | |||
| 2014-09-30 | $4.60M 10-Q · filed 2015-11-13 | $4.52M 10-Q · filed 2014-11-13 | $8.68M derived: sum of 2 quarters · filed 2015-11-13 | $11.20M 10-Q · filed 2015-11-13 | $10.96M 10-Q · filed 2014-11-13 | $14.58M derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $4.08M 10-Q · filed 2015-08-19 | $3.91M 10-Q · filed 2014-08-13 | $6.60M 10-Q · filed 2015-08-19 | $6.44M 10-Q · filed 2014-08-13 | $9.98M derived: sum of 3 quarters · filed 2015-10-30 | $12.17M derived: sum of 4 quarters · filed 2015-10-30 | ||
| 2014-03-31 | $2.53M 8-K · filed 2015-10-30 | $5.91M derived: sum of 2 quarters · filed 2015-10-30 | $8.09M derived: sum of 3 quarters · filed 2015-10-30 | $9.54M derived: sum of 4 quarters · filed 2015-10-30 | ||||
| 2013-12-31 | $3.38M derived: 8-K 12 month − 10-Q 9 month · filed 2015-10-30 | $5.57M derived: sum of 2 quarters · filed 2015-10-30 | $7.01M derived: sum of 3 quarters · filed 2015-10-30 | $8.74M 8-K · filed 2015-10-30 | $7.76M 10-K · filed 2015-03-30 | |||
| 2013-09-30 | $2.19M 10-Q · filed 2014-11-13 | $3.63M derived: sum of 2 quarters · filed 2014-11-13 | $5.37M 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | $1.45M 10-Q · filed 2014-08-13 | $3.18M 10-Q · filed 2014-08-13 | ||||||
| 2013-03-31 | $1.73M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |